FindTrial
Sign In

Oral Polio Vaccine

BIOLOGICAL9 trials

Sponsors

Sanofi Pasteur, a Sanofi Company, Bandim Health Project, PATH, Fidec Corporation, International Centre for Diarrhoeal Disease Research, Bangladesh

Conditions

ChildrenDiphtheriaHaemophilus InfectionsHaemophilus Influenzae Type bHealthyHepatitis BImmunity to Oral Polio VaccineImmunity to Oral Rotavirus Vaccine

Phase 3

Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine
CompletedNCT00343889
Sanofi Pasteur, a Sanofi CompanyDiphtheria, Haemophilus Infections, Hepatitis B +2
Start: 2006-08-31End: 2008-04-30Updated: 2013-12-10
Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants
CompletedNCT00514709
Sanofi Pasteur, a Sanofi CompanyDiphtheria, Hepatitis B, Influenza +2
Start: 2007-09-30End: 2009-04-30Updated: 2016-08-02
Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™
CompletedNCT00534833
Sanofi Pasteur, a Sanofi CompanyDiphtheria, Haemophilus Influenzae Type b, Hepatitis B +2
Start: 2007-09-30End: 2009-03-31Updated: 2013-11-21
Immunogenicity of Co-administered Oral Polio Vaccine and Oral Cholera Vaccine
NCT03581734
International Centre for Diarrhoeal Disease Research, BangladeshVaccine Reaction
Start: 2018-07-01End: 2022-10-25Target: 579Updated: 2022-03-31

Phase 4

Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus Vaccines
CompletedNCT01616693
PATHImmunity to Oral Polio Vaccine, Immunity to Oral Rotavirus Vaccine, Shedding of Oral Rotavirus Vaccine
Start: 2012-07-31End: 2013-07-31Updated: 2018-12-26
A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age
CompletedNCT02580201
Fidec CorporationPoliomyelitis
Start: 2015-11-30End: 2016-08-11Updated: 2023-04-18
Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children
CompletedNCT03460002
Bandim Health ProjectChildren, Measles Vaccination, Morbidity +3
Start: 2016-11-30End: 2022-08-31Updated: 2024-09-03
The Non-Specific Immunological Effects of Providing Oral Polio Vaccine to Seniors in Guinea-Bissau
Enrolling by invitationNCT06266754
Bandim Health ProjectVaccine Reaction
Start: 2024-01-29End: 2024-12-31Target: 80Updated: 2024-02-20

Unknown Phase

Investigating the Mortality and the Morbidity Impact of Oral Polio Vaccine at Birth
NCT00710983
Bandim Health ProjectHealthy, Infant, Newborn
Start: 2008-07-31End: 2015-01-31Updated: 2013-11-15

Related Papers

Co-administration of Oral Cholera Vaccine With Oral Polio Vaccine Among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference
Clinical Infectious Diseases2022-09-223 citations
Reduction in Short-term Outpatient Consultations After a Campaign With Measles Vaccine in Children Aged 9–59 Months: Substudy Within a Cluster-Randomized Trial
Journal of the Pediatric Infectious Diseases Society2020-07-146 citations
Research protocol of two concurrent cluster-randomized trials: Real-life Effect of a CAMPaign with Measles Vaccination (RECAMP-MV) and Real-life Effect of a CAMPaign with Oral Polio Vaccination (RECAMP-OPV) on mortality and morbidity among children in rural Guinea-Bissau
BMC Public Health2019-11-118 citations
The Effect of Oral Polio Vaccine at Birth on Infant Mortality: A Randomized Trial
Clinical Infectious Diseases2015-07-28190 citations